🌍·2d agoResearch
Updated survival outcomes of SYHX2011 versus albumin-bound paclitaxel in advanced breast cancer: A randomized double-blind phase III trial.
Publisher
E
Europe PMC
EU
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Europe PMC
- Region
- EU
- Scope
- Research
- Published
- July 21, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on europepmc.org
Leave the platform to read the original full article on the publisher site.
Source: Europe PMC
Scope: Research
Related coverage
More related coverage
Crossref/6h ago
Drug-Drug Interaction Signals for Sexual Dysfunction with Antidepressants and Antipsychotics: A Pharmacovigilance-Pharmacodynamic Study
Crossref/6h ago
Device-Associated Infections Caused by <i>Escherichia coli</i> in Hospitalized Patients: Mechanisms and Clinical Impact
Crossref/6h ago
Clinical and Molecular Characterization of Rare Inherited Metabolic Disorders in a Tertiary Care Genetics Clinic
Crossref/6h ago